| Title | Microenvironment-Driven Dynamic Chromatin Changes in Glioblastoma Recapitulate Early Neural Development at Single-Cell Resolution. |
| Publication Type | Journal Article |
| Year of Publication | 2023 |
| Authors | Pine AR, Cirigliano SM, Singhania R, Nicholson J, da Silva B, Leslie CS, Fine HA |
| Journal | Cancer Res |
| Volume | 83 |
| Issue | 10 |
| Pagination | 1581-1595 |
| Date Published | 2023 May 15 |
| ISSN | 1538-7445 |
| Keywords | Brain Neoplasms, Cell Line, Tumor, Chromatin, Glioblastoma, Glioma, Humans, Tumor Microenvironment |
| Abstract | UNLABELLED: The tumor microenvironment is necessary for recapitulating the intratumoral heterogeneity and cell state plasticity found in human primary glioblastoma (GBM). Conventional models do not accurately recapitulate the spectrum of GBM cellular states, hindering elucidation of the underlying transcriptional regulation of these states. Using our glioblastoma cerebral organoid model, we profiled the chromatin accessibility of 28,040 single cells in five patient-derived glioma stem cell lines. Integration of paired epigenomes and transcriptomes within the context of tumor-normal host cell interactions was used to probe the gene-regulatory networks underlying individual GBM cellular states in a way not readily possible in other in vitro models. These analyses identified the epigenetic underpinnings of GBM cellular states and characterized dynamic chromatin changes reminiscent of early neural development that underlie GBM cell state transitions. Despite large differences between tumors, a shared cellular compartment made up of neural progenitor-like cells and outer radial glia-like cells was observed. Together, these results shed light on the transcriptional regulation program in GBM and offer novel therapeutic targets across a broad range of genetically heterogenous GBMs. SIGNIFICANCE: Single-cell analyses elucidate the chromatin landscape and transcriptional regulation of glioblastoma cellular states and identify a radial glia-like population, providing potential targets to disrupt cell states and improve therapeutic efficacy. |
| DOI | 10.1158/0008-5472.CAN-22-2872 |
| Alternate Journal | Cancer Res |
| PubMed ID | 36877162 |
| PubMed Central ID | PMC11022245 |
| Grant List | U54 CA274492 / CA / NCI NIH HHS / United States T32 GM132083 / GM / NIGMS NIH HHS / United States P30 CA008748 / CA / NCI NIH HHS / United States U54 CA209975 / CA / NCI NIH HHS / United States DP1 CA228040 / CA / NCI NIH HHS / United States |
